Staphylococcus haemolytics: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==Staphylococcus haemolyticus== ===Treatment=== :* 1. '''Methicillin-susceptible strain'''<ref>{{cite book | last = Abramowicz | first = Mark | title = Handbook of antimicrobi...") |
|||
Line 12: | Line 12: | ||
::* Preferred regimen (1): [[Daptomycin]] 4–6 mg/kg IV q24h | ::* Preferred regimen (1): [[Daptomycin]] 4–6 mg/kg IV q24h | ||
::* Preferred regimen (2): [[Linezolid]] 600 mg PO/IV q12h | ::* Preferred regimen (2): [[Linezolid]] 600 mg PO/IV q12h | ||
==References== | |||
{{Reflist|2}} |
Latest revision as of 20:13, 28 July 2015
Staphylococcus haemolyticus
Treatment
-
- Preferred regimen (1): Nafcillin 1–2 g IV q4-6h (maximum 12 g/day)
- Preferred regimen (2): Oxacillin 1–2 g IVq4-6h (maximum 12 g/day)
- Preferred regimen (3): Cefazolin 0.5–2 g IV q6-8h
- Alternative regimen (1): TMP-SMX 4–5 mg/kg IV q6–12h
- Alternative regimen (2): Doxycycline 100–200 mg IV q12-24h
- 2. Methicillin-resistant, Glycopeptide-susceptible strain
- Preferred regimen: Vancomycin 15–20 mg/kg IV q8–12h
- 3. Methicillin-resistant, Glycopeptide-resistant strain
- Preferred regimen (1): Daptomycin 4–6 mg/kg IV q24h
- Preferred regimen (2): Linezolid 600 mg PO/IV q12h
References
- ↑ Abramowicz, Mark (2011). Handbook of antimicrobial therapy : selected articles from Treatment guidelines with updates from The medical letter. New Rochelle, N.Y: The Medical Letter. ISBN 978-0981527826.
- ↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.